JPMorgan Chase & Co’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,219
| Closed | -$1.94K | – | 6789 |
|
|
2023
Q2 | $1.94K | Buy |
10,219
+2,475
| +32% | +$470 | ﹤0.01% | 5437 |
|
|
2023
Q1 | $3K | Sell |
7,744
-1,611
| -17% | -$624 | ﹤0.01% | 5510 |
|
|
2022
Q4 | $3K | Sell |
9,355
-289
| -3% | -$93 | ﹤0.01% | 5333 |
|
|
2022
Q3 | $4K | Buy |
9,644
+383
| +4% | +$159 | ﹤0.01% | 5257 |
|
|
2022
Q2 | $4K | Sell |
9,261
-2,188
| -19% | -$945 | ﹤0.01% | 5362 |
|
|
2022
Q1 | $14K | Sell |
11,449
-632
| -5% | -$773 | ﹤0.01% | 5335 |
|
|
2021
Q4 | $15K | Sell |
12,081
-99
| -0.8% | -$123 | ﹤0.01% | 5378 |
|
|
2021
Q3 | $25K | Sell |
12,180
-24,832
| -67% | -$51K | ﹤0.01% | 5100 |
|
|
2021
Q2 | $58K | Sell |
37,012
-87,329
| -70% | -$137K | ﹤0.01% | 4907 |
|
|
2021
Q1 | $276K | Sell |
124,341
-4,263
| -3% | -$9.46K | ﹤0.01% | 4332 |
|
|
2020
Q4 | $318K | Buy |
128,604
+87,057
| +210% | +$215K | ﹤0.01% | 3980 |
|
|
2020
Q3 | $109K | Sell |
41,547
-1,437
| -3% | -$3.77K | ﹤0.01% | 4006 |
|
|
2020
Q2 | $153K | Buy |
+42,984
| New | +$153K | ﹤0.01% | 3793 |
|
|
2020
Q1 | – | Sell |
-18,930
| Closed | -$42K | – | 4894 |
|
|
2019
Q4 | $42K | Sell |
18,930
-907
| -5% | -$2.01K | ﹤0.01% | 4289 |
|
|
2019
Q3 | $37K | Buy |
19,837
+646
| +3% | +$1.21K | ﹤0.01% | 4349 |
|
|
2019
Q2 | $30K | Sell |
19,191
-7,722
| -29% | -$12.1K | ﹤0.01% | 4438 |
|
|
2019
Q1 | $53K | Buy |
26,913
+1,098
| +4% | +$2.16K | ﹤0.01% | 4215 |
|
|
2018
Q4 | $34K | Buy |
25,815
+18,315
| +244% | +$24.1K | ﹤0.01% | 4384 |
|
|
2018
Q3 | $18K | Sell |
7,500
-2,075
| -22% | -$4.98K | ﹤0.01% | 4589 |
|
|
2018
Q2 | $32K | Buy |
9,575
+218
| +2% | +$729 | ﹤0.01% | 4450 |
|
|
2018
Q1 | $40K | Buy |
9,357
+1,761
| +23% | +$7.53K | ﹤0.01% | 4225 |
|
|
2017
Q4 | $25K | Buy |
+7,596
| New | +$25K | ﹤0.01% | 4347 |
|